Based on The Cancer Genome Atlas (TCGA) project, GC is divided into four subtypes, and promising therapeutic targets, such as human epidermal growth factor receptor 2 (HER2), have been identified (12, 13). The gene discussed is ERBB2; the disease is gastric cancer.